Testosterone for Women: The Complete Guide
Testosterone is not a male hormone. It is the most abundant bioactive sex hormone in women throughout most of their adult life, and it is the one most likely to be undertreated, underprescribed, and under-discussed in women’s healthcare. Most women who present with low libido, persistent fatigue, loss of muscle tone, brain fog, and depressed mood are never told that testosterone deficiency could be a primary contributor. This guide explains what testosterone does in women, when it declines, and how it is appropriately prescribed.
Key takeaway: Testosterone is a primary female sex hormone that supports libido, energy, cognition, mood, muscle, and bone. It declines through perimenopause and drops sharply in surgical menopause. There are no FDA-approved testosterone products with female dosing in the United States, but the clinical evidence supports its use, and compounded testosterone prepared for women allows precise, low-dose physiological replacement.
Why Women Need Testosterone
Female testosterone production occurs primarily in the ovaries and adrenal glands. In premenopausal women, testosterone levels are approximately 10 to 20 times lower than in men, but the receptors that respond to testosterone are distributed throughout the female body just as they are in men, in the brain, muscle, bone, skin, cardiovascular system, and genitourinary tract. Testosterone in women supports several body systems at once:
- Libido and sexual function. Testosterone is the primary driver of sexual desire in women; low T is the most common hormonal cause of hypoactive sexual desire disorder (HSDD).
- Muscle mass and strength. Testosterone stimulates muscle protein synthesis in women; declining T accelerates age-related muscle loss (sarcopenia) independent of estrogen status.
- Energy and motivation. Testosterone modulates dopamine pathways involved in drive, motivation, and reward; low T produces a specific type of fatigue characterized by reduced initiative and enjoyment.
- Cognitive function. Testosterone receptors are abundant in the hippocampus and prefrontal cortex; low T is associated with word-finding difficulty, reduced processing speed, and poor concentration.
- Bone density. Testosterone contributes to bone maintenance independently of estrogen; testosterone deficiency accelerates bone loss.
- Mood and emotional resilience. Low testosterone in women is associated with depressive symptoms, emotional flatness, and reduced stress tolerance.
When Female Testosterone Declines
Female testosterone peaks in the mid-20s and declines gradually thereafter. The steepest decline occurs during the perimenopause transition, when ovarian production falls, and accelerates sharply in surgical menopause when both ovaries are removed. By the time a woman is fully postmenopausal, her testosterone levels may be 50 to 70 percent lower than peak levels.
There is no universally agreed-upon clinical definition of “low testosterone” in women because reference ranges have been poorly established in large female populations. What our medical team evaluates is the clinical picture: symptoms plus labs, rather than relying on a single cutoff number. The Global Consensus Position Statement on the Use of Testosterone Therapy for Women, published in JCEM, recognizes the clinical reality of female testosterone deficiency and supports physiological-dose testosterone for women with HSDD that has not responded to other interventions.
The HSDD conversation most providers skip: Hypoactive sexual desire disorder, persistent and distressing low or absent sexual desire, affects an estimated 8 to 14 percent of women. It is the most common female sexual dysfunction. Low testosterone is the most frequently identified hormonal contributor. Despite this, testosterone is not FDA-approved for women in the United States for this indication, which means most women are never offered it as a treatment option, even though the clinical evidence supports its use.
Symptoms of Low Testosterone in Women
Low testosterone in women shows up across several body systems, and the picture rarely fits a single complaint. Our medical team evaluates the cluster of symptoms below alongside lab values rather than relying on any single marker.
- Low or absent libido, reduced sexual desire that feels different from your baseline
- Reduced arousal and difficulty with orgasm
- Persistent fatigue that does not improve with sleep
- Loss of muscle tone despite exercise
- Increased body fat, especially visceral fat
Cognitive, mood, and physical changes round out the picture and are often what brings a woman in for evaluation rather than the sexual symptoms alone:
- Brain fog, poor concentration, word-finding difficulty
- Mood changes, emotional flatness, reduced enthusiasm, low motivation
- Thinning hair and dry skin
- Reduced bone density on DEXA
How Testosterone for Women Is Prescribed
Because there are no FDA-approved testosterone products with female dosing indications in the United States, our medical team uses compounded testosterone from licensed compounding pharmacies. Compounded testosterone is prepared in doses appropriate for women, typically 0.5 to 2 mg per day, compared to 50 to 100 mg per day for men, reflecting the physiological difference in required levels.
We use two main delivery options for female patients. Topical cream or gel is the most common: applied to the inner arms, inner thighs, or labia minora daily, it allows precise dose titration. Sublingual troches dissolved under the tongue offer faster absorption and are used when topical application is not tolerated. The global testosterone position statement led by Davis and colleagues supports transdermal delivery as the preferred route for female testosterone replacement and recommends against routine pellet implants, which produce supraphysiologic levels that often exceed female reference ranges.
Testosterone for women is almost always prescribed as part of a broader HRT protocol that includes estradiol and, in intact-uterus patients, micronized progesterone. It is rarely prescribed in isolation. For broader context on the modern HRT formulation, see our guide on BHRT vs synthetic HRT.
What to Expect on Female Testosterone Therapy
The timeline of benefit for women on testosterone therapy generally follows a predictable pattern. Energy and mood typically improve first, libido and sexual function follow, and the structural changes (muscle, bone, body composition) develop over months. Individual response varies based on baseline levels, dose, and concurrent estradiol and progesterone status.
- Weeks 2 to 4. Energy and mood typically improve first, often described as feeling more like yourself.
- Weeks 4 to 8. Libido and sexual desire begin to improve; arousal and sensitivity often improve before desire.
- Months 2 to 4. Cognitive improvements, sharper focus, better word retrieval, reduced brain fog.
- Months 3 to 6. Body composition changes, improved muscle tone with exercise, modest reduction in visceral fat.
The typical monitoring schedule includes a follow-up lab panel at 6 to 8 weeks after starting to assess free testosterone, total testosterone, and SHBG, with dose adjustment as needed. Ongoing monitoring at 6 to 12 month intervals continues for as long as therapy is maintained.
Our medical team evaluates the full hormone picture (estrogen, progesterone, AND testosterone) for every female patient. Free consultation in Sugar Hill, GA or telehealth for Georgia patients.
Book Free Consultation- Hypoactive sexual desire disorder (HSDD)
- Persistent and distressing low or absent sexual desire that is not better explained by another condition. Affects an estimated 8 to 14 percent of women and is the most common female sexual dysfunction.
- Compounded testosterone
- Testosterone prepared by a licensed compounding pharmacy in doses appropriate for women (typically 0.5 to 2 mg per day). Used because no FDA-approved testosterone product is available with female dosing indications in the United States.
- SHBG (sex hormone-binding globulin)
- A liver protein that binds to testosterone and estradiol in the blood. Elevated SHBG can lower the amount of free, biologically active testosterone available to tissues, even when total testosterone appears normal.
- Free testosterone
- The portion of total testosterone not bound to SHBG or albumin. Free testosterone is the biologically active fraction that interacts with receptors. Free testosterone is the more clinically meaningful measurement in women than total testosterone alone.
- Surgical menopause
- The abrupt onset of menopause caused by surgical removal of both ovaries (bilateral oophorectomy). Produces a sharper testosterone drop than natural menopause because the ovaries continue to produce some testosterone even after natural menopause.
